| The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity J Barretina, G Caponigro, N Stransky, K Venkatesan, AA Margolin, S Kim, ... Nature 483 (7391), 603, 2012 | 7721 | 2012 |
| Next-generation characterization of the Cancer Cell Line Encyclopedia M Ghandi, FW Huang, J Jané-Valbuena, GV Kryukov, CC Lo, ... Nature 569 (7757), 503, 2019 | 2380 | 2019 |
| Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma S Buonamici, J Williams, M Morrissey, A Wang, R Guo, A Vattay, K Hsiao, ... Science translational medicine 2 (51), 51ra70-51ra70, 2010 | 523 | 2010 |
| Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia EJ Orlando, X Han, C Tribouley, PA Wood, RJ Leary, M Riester, JE Levine, ... Nature medicine 24 (10), 1504, 2018 | 467 | 2018 |
| Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma R Rahal, M Frick, R Romero, JM Korn, R Kridel, FC Chan, B Meissner, ... Nature medicine 20 (1), 87, 2014 | 395 | 2014 |
| Pharmacogenomic agreement between two cancer cell line data sets TGDSC Consortium, The Cancer Cell Line Encyclopedia Consortium Nature 528, 84-87, 2015 | 340* | 2015 |
| Association of MTOR mutations with developmental brain disorders, including megalencephaly, focal cortical dysplasia, and pigmentary mosaicism GM Mirzaa, CD Campbell, N Solovieff, CP Goold, LA Jansen, S Menon, ... JAMA neurology 73 (7), 836-845, 2016 | 263 | 2016 |
| Association of MTOR mutations with developmental brain disorders, including megalencephaly, focal cortical dysplasia, and pigmentary mosaicism K Campbell, N Solovieff, M Morrissey, R Leary, S Mahan, W Adamovich, ... JAMA Neurology 73 (7), 836-845, 2016 | 259 | 2016 |
| Identification of cervical cancer markers by cDNA and tissue microarrays Y Chen, C Miller, R Mosher, X Zhao, J Deeds, M Morrissey, B Bryant, ... Cancer research 63 (8), 1927-1935, 2003 | 214 | 2003 |
| The Cancer Cell Line Encyclopedia-Using Preclinical Models to Predict Anticancer Drug Sensitivity J Barretina, G Caponigro, N Stransky, K Venkatesan, AA Margolin, S Kim, ... EUROPEAN JOURNAL OF CANCER 48, S5-S6, 2012 | 189* | 2012 |
| Evidence for the role of PrPC helix 1 in the hydrophilic seeding of prion aggregates MP Morrissey, EI Shakhnovich Proceedings of the National Academy of Sciences 96 (20), 11293-11298, 1999 | 156 | 1999 |
| Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis D Wiederschain, L Chen, B Johnson, K Bettano, D Jackson, J Taraszka, ... Molecular and cellular biology 27 (13), 4968-4979, 2007 | 142 | 2007 |
| PureCN: copy number calling and SNV classification using targeted short read sequencing DYCMPM Markus Riester, Angad P. Singh, A. Rose Brannon, Kun Yu, Catarina D ... Source Code for Biology and Medicine 11 (13), 2016 | 123 | 2016 |
| Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features JJ Pitt, M Riester, Y Zheng, TF Yoshimatsu, A Sanni, O Oluwasola, ... Nature communications 9 (1), 4181, 2018 | 96 | 2018 |
| The Polycomb group protein Bmi-1 is essential for the growth of multiple myeloma cells Z Jagani, D Wiederschain, A Loo, D He, R Mosher, P Fordjour, ... Cancer research 70 (13), 5528-5538, 2010 | 94 | 2010 |
| Design of proteins with selected thermal properties MP Morrissey, EI Shakhnovich Folding and design 1 (5), 391-405, 1996 | 80 | 1996 |
| Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy G Mulligan, B Bryant, M Morrissey, A Bolt, A Damokosh US Patent App. 10/728,055, 2004 | 59 | 2004 |
| NUCLEIC ACID MOLECULES AND PROTEINS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF OVARIAN CANCER J MONAHAN, M GANNAVARAPU, S HOERSCH, S KAMATKAR, ... WO Patent 2,002,071,928, 2002 | 56 | 2002 |
| Use of Circulating Tumor DNA for Cancer Immunotherapy A Snyder, MP Morrissey, MD Hellmann Clinical Cancer Research, clincanres. 2688.2019, 2019 | 43 | 2019 |
| Genomic profiling of NETs: a comprehensive analysis of the RADIANT trials JC Yao, A Garg, D Chen, J Capdevila, P Engstrom, R Pommier, ... Endocrine-related cancer 1 (aop), 2019 | 42 | 2019 |
